Literature DB >> 19641484

Exercise ameliorates chronic kidney disease-induced defects in muscle protein metabolism and progenitor cell function.

Xiaonan H Wang1, Jie Du, Janet D Klein, James L Bailey, William E Mitch.   

Abstract

Chronic kidney disease (CKD) impairs muscle protein metabolism leading to muscle atrophy, and exercise can counteract this muscle wasting. Here we evaluated how resistance exercise (muscle overload) and endurance training (treadmill running) affect CKD-induced abnormalities in muscle protein metabolism and progenitor cell function using mouse plantaris muscle. Both exercise models blunted the increase in disease-induced muscle proteolysis and improved phosphorylation of Akt and the forkhead transcription factor FoxO1. Muscle overloading, but not treadmill running, corrected protein synthesis and levels of mediators of protein synthesis such as phosphorylated mTOR and p70S6K in the muscles of mice with CKD. In these mice, muscle overload, but not treadmill, running, increased muscle progenitor cell number and activity as measured by the amounts of MyoD, myogenin, and eMyHC mRNAs. Muscle overload not only increased plantaris weight and reduced muscle proteolysis but also corrected intracellular signals regulating protein and progenitor cell function in mice with CKD. Treadmill running corrects muscle proteolysis but not protein synthesis or progenitor cell function. Our results provide a basis for evaluating different types of exercise on muscle atrophy in patients with chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19641484      PMCID: PMC3835682          DOI: 10.1038/ki.2009.260

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  35 in total

Review 1.  Satellite cell depletion in degenerative skeletal muscle.

Authors:  S S Jejurikar; W M Kuzon
Journal:  Apoptosis       Date:  2003-12       Impact factor: 4.677

2.  Malnutrition: a frequent misdiagnosis for hemodialysis patients.

Authors:  William E Mitch
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

3.  Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions.

Authors:  Jie Du; Xiaonan Wang; Christiane Miereles; James L Bailey; Richard Debigare; Bin Zheng; S Russ Price; William E Mitch
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

4.  Phosphatidic acid-mediated mitogenic activation of mTOR signaling.

Authors:  Y Fang; M Vilella-Bach; R Bachmann; A Flanigan; J Chen
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

5.  Resistance exercise alters MRF and IGF-I mRNA content in human skeletal muscle.

Authors:  Niklas Psilander; Rasmus Damsgaard; Henriette Pilegaard
Journal:  J Appl Physiol (1985)       Date:  2003-04-25

6.  Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.

Authors:  Marco Sandri; Claudia Sandri; Alex Gilbert; Carsten Skurk; Elisa Calabria; Anne Picard; Kenneth Walsh; Stefano Schiaffino; Stewart H Lecker; Alfred L Goldberg
Journal:  Cell       Date:  2004-04-30       Impact factor: 41.582

7.  Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression.

Authors:  Stewart H Lecker; R Thomas Jagoe; Alexander Gilbert; Marcelo Gomes; Vickie Baracos; James Bailey; S Russ Price; William E Mitch; Alfred L Goldberg
Journal:  FASEB J       Date:  2004-01       Impact factor: 5.191

8.  The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.

Authors:  Trevor N Stitt; Doreen Drujan; Brian A Clarke; Frank Panaro; Yekatarina Timofeyva; William O Kline; Michael Gonzalez; George D Yancopoulos; David J Glass
Journal:  Mol Cell       Date:  2004-05-07       Impact factor: 17.970

9.  Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-alpha activator.

Authors:  Ellen Aasum; Darrell D Belke; David L Severson; Rudolph A Riemersma; Marie Cooper; Morten Andreassen; Terje S Larsen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-09       Impact factor: 4.733

10.  IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting.

Authors:  Liping Zhang; Jie Du; Zhaoyong Hu; Guofeng Han; Patrice Delafontaine; Gabriela Garcia; William E Mitch
Journal:  J Am Soc Nephrol       Date:  2009-01-21       Impact factor: 10.121

View more
  48 in total

1.  Oxidative stress contributes to muscle atrophy in chronic kidney disease patients.

Authors:  Kassia S Beetham; Erin J Howden; David M Small; David R Briskey; Megan Rossi; Nicole Isbel; Jeff S Coombes
Journal:  Redox Rep       Date:  2014-11-13       Impact factor: 4.412

2.  MicroRNA-23a and MicroRNA-27a Mimic Exercise by Ameliorating CKD-Induced Muscle Atrophy.

Authors:  Bin Wang; Cong Zhang; Aiqing Zhang; Hui Cai; S Russ Price; Xiaonan H Wang
Journal:  J Am Soc Nephrol       Date:  2017-04-11       Impact factor: 10.121

Review 3.  Mechanisms of muscle wasting in chronic kidney disease.

Authors:  Xiaonan H Wang; William E Mitch
Journal:  Nat Rev Nephrol       Date:  2014-07-01       Impact factor: 28.314

4.  PTEN inhibition improves muscle regeneration in mice fed a high-fat diet.

Authors:  Zhaoyong Hu; Huiling Wang; In Hee Lee; Swati Modi; Xiaonan Wang; Jie Du; William E Mitch
Journal:  Diabetes       Date:  2010-03-03       Impact factor: 9.461

5.  Inhibition of urea transporter ameliorates uremic cardiomyopathy in chronic kidney disease.

Authors:  Akihiro Kuma; Xiaonan H Wang; Janet D Klein; Lin Tan; Nawazish Naqvi; Fitra Rianto; Ying Huang; Manshu Yu; Jeff M Sands
Journal:  FASEB J       Date:  2020-05-04       Impact factor: 5.191

6.  Impact of chronic kidney disease and anemia on physical function in patients with chronic heart failure.

Authors:  Masakazu Saitoh; Haruki Itoh; Nobuo Morotomi; Tetsuya Ozawa; Noriko Ishii; Reina Uewaki; Kentaro Hori; Yohei Shiotani; Miki Ando; Shogo Nakashima; Kana Kawai; Azusa Ohno; Masatoshi Nagayama
Journal:  Cardiorenal Med       Date:  2014-04-17       Impact factor: 2.041

7.  Can muscle-kidney crosstalk slow progression of CKD?

Authors:  Helbert Rondon-Berrios; Yanlin Wang; William E Mitch
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

8.  Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.

Authors:  James P White; Melissa J Puppa; Song Gao; Shuichi Sato; Stephen L Welle; James A Carson
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-03-26       Impact factor: 4.310

9.  Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy.

Authors:  Liping Zhang; Xiaonan H Wang; Huiling Wang; Jie Du; William E Mitch
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

Review 10.  MicroRNA in myogenesis and muscle atrophy.

Authors:  Xiaonan H Wang
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-05       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.